Clinical trial
A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major…
NCT00402220 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00402220 |
|---|---|
| Title | A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression |
| Official title | A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression |
| Lead sponsor | Bayside Health, Other |
| Collaborators | National Health and Medical Research Council, Australia |
| Status | Completed |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Device, Drug |
| Interventions | TMS, Sham TMS |
| Enrollment | 67 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Nov 22, 2006 |
| Last update posted | Oct 19, 2020 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: